Company
Abbott
Official Name: Abbott Laboratories
Headquarters: North Chicago, IL, United States
Founded: 1888
Employees: 113,000
CEO: Mr. Robert B. Ford
Market Cap
$178.02 Billion
USD as of July 1, 2024
Company Description
Abbott Laboratories is a multinational health care and medical devices company. Founded in 1888, Abbot manufactures medical devices including cardiovascular and neuromodulation devices, diagnostics products, branded generic medicines, and nutritional products for children and adults including Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.
Top Competitors by Market Capitalization
Industry: Medical Devices
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Abbott Laboratories has the following listings and related stock indices.
Stock: NYSE: ABT wb_incandescent
Stock: BCBA: ABT wb_incandescent
Stock: BMV: ABT wb_incandescent
Stock: Bovespa: ABTT34 wb_incandescent
Stock: BVS: ABTCL wb_incandescent
Stock: FSX: ABL wb_incandescent
Stock: XETR: ABL wb_incandescent
Product & Services
Branded generic medicinesMedical devicesDiagnostic assaysNutritionals
Key People
Founder(s): Dr. Wallace Calvin Abbott
Miles D. White (Executive Chairman) Robert B. Ford (President & CEO) Robert Funck (Executive Vice President & CFO)
Financials
Revenue: US$34.608 billion (2020)
Operating income: US$5.357 billion (2020)
Net income: US$4.495 billion (2020)
Total assets: US$72.548 billion (2020)
Total equity: US$33.003 billion (2020)